Healthcare is entering a demographic supercycle. Is your investment strategy ready?
Demography is becoming one of the most powerful drivers of long-term capital allocation. Ageing populations, declining fertility, scientific breakthroughs and AI are reshaping healthcare faster than most investment frameworks can adapt.
I help institutional investors understand where long-term value is being created, evaluate emerging healthcare markets, and make better investment decisions before they become institutional consensus.

“20+ years advising institutional capital on manager selection and portfolio construction.”




Demography is rewriting the economics of healthcare. Most investment frameworks haven't caught up.
Healthcare is no longer simply a defensive sector. Ageing populations, scientific breakthroughs and precision medicine are reshaping where long-term value will be created.
Increasingly, that value is being created in private markets — long before companies reach the public markets, if they ever do.
The challenge isn't just access. It's judgement.
Strategic questions for institutional investors.
- 01
Should we allocate capital here?
Emerging healthcare markets require a different investment framework from traditional healthcare investing. I help investors evaluate whether new markets deserve a strategic allocation and the most appropriate way to gain exposure.
Learn more → - 02
How do we assess markets that don't yet have long-term track records?
Many of tomorrow's investment opportunities lack decades of historical performance. Together we develop institutional-quality frameworks for evaluating emerging healthcare themes before benchmarks exist.
Learn more → - 03
Where is long-term value being created?
Scientific progress does not always translate into investment opportunity. I identify where demographic change, innovation and commercial adoption intersect to create durable value.
Learn more → - 04
How do we build conviction before markets become obvious?
The greatest opportunities rarely feel obvious at the beginning. I help investment committees build evidence-based conviction through independent research, manager evaluation and strategic insight.
Learn more →
Institutional investment experience. Specialist healthcare insight.
For more than twenty years I advised private banks, family offices and institutional investors on complex investment decisions. Today I apply that experience to one of investing's fastest-changing landscapes. My work sits at the intersection of demographic change, healthcare innovation, institutional investing and capital allocation strategy. Whether advising investors, speaking to leadership teams or contributing to strategic discussions, my objective is the same: help decision-makers recognise structural shifts before they become obvious — and understand what they mean for capital allocation.
20+ Years
Institutional investment experience
USD 5bn+
Investment oversight
Global Speaker
International investment and healthcare conferences
Author
The Billion Dollar Blindspot
Perspectives on the future of healthcare capital.

The Billion Dollar Blindspot in Women's Healthcare
Wealth Office

The US$100 Billion Longevity Market
Keynote, SIP-BILANZ Health & Longevity Conference, 20 May 2026, Zurich

The Women's Health Capital Thesis: Why Precision Health Is Becoming an Institutional Investment Opportunity
The Billion Dollar Blindspot
Independent insight for important investment decisions.
Strategic Advisory
Independent strategic advice for institutional investors evaluating emerging healthcare markets.
Executive Briefings
Private briefings for family offices, investment committees and leadership teams.
Keynote Speaking
Helping institutional audiences understand how healthcare innovation is reshaping long-term investing.
Let's discuss your next investment decision.
Whether you are evaluating an emerging healthcare investment theme, exploring its implications for portfolio construction or seeking an independent strategic perspective, every engagement begins with a conversation.